What is Octahydrocoumarin?
Octahydrocoumarin, also known as 4,4a,5,6,7,8-hexahydro-4a-methyl-2H-chromen-2-one, is a synthetic organic compound belonging to the coumarin family of flavoring molecules. It is the saturated derivative of coumarin, with a molecular formula of C₁₀H₁₆O₂ and CAS number 4430-31-3. The compound exists as a colorless to pale yellow liquid with a characteristic sweet, vanilla-like, and woody aroma profile.
Common Uses
Octahydrocoumarin is used primarily as a flavoring agent and flavor adjuvant in the food and beverage industry. Its sensory profile makes it valuable in formulations requiring vanilla, woody, and warm aromatic notes. Common applications include:
- Beverages (soft drinks, flavored waters, alcoholic beverages)
- Confectionery and candy products
- Baked goods and desserts
- Dairy products (yogurts, ice creams)
- Fragrance-food combinations where coumarin-type notes are desired
The saturated structure of octahydrocoumarin offers advantages over natural coumarin, including improved stability and the potential for reduced concerns associated with certain properties of unsaturated coumarins.
Safety Assessment
Octahydrocoumarin has not been submitted for GRAS (Generally Recognized as Safe) approval with the FDA. However, the compound has generated zero reported adverse events in FDA databases and zero product recalls, indicating no documented safety incidents from consumer exposure at current levels of use.
The safety profile of octahydrocoumarin should be considered within the context of coumarin chemistry. Natural coumarin and related compounds have long histories of use in food flavoring. The saturated nature of octahydrocoumarin distinguishes it structurally from coumarin itself, potentially affecting its biological activity and metabolism.
Limited published toxicological data exists specifically for octahydrocoumarin compared to other coumarin derivatives. The lack of adverse event reports suggests either limited use at low concentrations, good tolerance at levels of dietary exposure, or both.
Regulatory Status
In the United States, octahydrocoumarin does not hold GRAS status with the FDA. Manufacturers using this substance would require either GRAS affirmation through the FDA's GRAS notification program or compliance with Food Additive Petition procedures, though such petition status is not publicly documented for this compound.
In the European Union, octahydrocoumarin is not listed on the EFSA's approved flavoring substances list as of standard database records, meaning it would require separate authorization for use in EU member states.
The regulatory pathway for octahydrocoumarin remains limited compared to more widely approved coumarin derivatives, which may reflect either low commercial demand, ongoing review processes, or intentional market limitations by manufacturers.
Key Studies
Published scientific literature specifically examining octahydrocoumarin toxicology or safety is sparse. Most relevant safety information derives from:
1. General coumarin safety literature, which establishes baseline safety profiles for coumarin-class compounds
2. Structural activity relationship (SAR) analysis of saturated versus unsaturated coumarins
3. Comparative metabolism studies of coumarin derivatives
The absence of adverse event data in FDA databases, combined with zero recalls, provides empirical evidence of safety at current consumer exposure levels, though this does not constitute comprehensive toxicological approval.
Any manufacturer considering octahydrocoumarin would benefit from consulting current toxicology databases and regulatory guidance specific to their intended market.